These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25877739)

  • 1. Visualization of the human coronary vasa vasorum in vivo.
    Tanaka K; Sata M
    Circ J; 2015; 79(6):1211-2. PubMed ID: 25877739
    [No Abstract]   [Full Text] [Related]  

  • 2. Accuracy of optical frequency domain imaging for evaluation of coronary adventitial vasa vasorum formation after stent implantation in pigs and humans - a validation study - .
    Nishimiya K; Matsumoto Y; Uzuka H; Oyama K; Tanaka A; Taruya A; Ogata T; Hirano M; Shindo T; Hanawa K; Hasebe Y; Hao K; Tsuburaya R; Takahashi J; Miyata S; Ito K; Akasaka T; Shimokawa H
    Circ J; 2015; 79(6):1323-31. PubMed ID: 25843557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue coverage and neointimal hyperplasia in overlap versus nonoverlap segments of drug-eluting stents 9 to 13 months after implantation: in vivo assessment with optical coherence tomography.
    Gutiérrez-Chico JL; Räber L; Regar E; Okamura T; di Mario C; van Es GA; Windecker S; Serruys PW
    Am Heart J; 2013 Jul; 166(1):83-94. PubMed ID: 23816026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of adventitial vasa vasorum formation at the coronary segment with myocardial bridge - An optical coherence tomography study.
    Nishimiya K; Matsumoto Y; Wang H; Piao Z; Ohyama K; Uzuka H; Hao K; Tsuburaya R; Takahashi J; Ito K; Shimokawa H
    Int J Cardiol; 2018 Jan; 250():275-277. PubMed ID: 28993001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Coronary Intimal Plaques by Optical Coherence Tomography in Arteries With Versus Without Internal Running Vasa Vasorum.
    Amano H; Koizumi M; Okubo R; Yabe T; Watanabe I; Saito D; Toda M; Ikeda T
    Am J Cardiol; 2017 May; 119(10):1512-1517. PubMed ID: 28347486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.
    Kim S; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Cho YK; Nam CW; Hur SH; Jang Y; Hong MK
    Am J Cardiol; 2013 Jan; 111(1):1-5. PubMed ID: 23040589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasa vasorum in normal and diseased arteries.
    Mulligan-Kehoe MJ; Simons M
    Circulation; 2014 Jun; 129(24):2557-66. PubMed ID: 24934463
    [No Abstract]   [Full Text] [Related]  

  • 8. Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent™ in combination with XIENCE-V™ stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluation of the TRYTON Side-Branch Stent™ with an additional XIENCE-v™ everolimus-eluting stent in coronary bifurcation lesions) study.
    Dubois C; Adriaenssens T; Ughi G; Wiyono S; Bennett J; Coosemans M; Ferdinande B; Sinnaeve P; D'hooge J; Desmet W
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):E155-64. PubMed ID: 22745031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Strut Coverage at 6 Months by Optical Coherence Tomography With Everolimus-Eluting Stenting of Bare-Metal Stent Restenosis Versus Stenosis of Nonstented Atherosclerotic Narrowing (from the DESERT Study).
    Picchi A; Musumeci G; Calabria P; Cresti A; Rescigno R; Aruffo A; Prati F; Limbruno U
    Am J Cardiol; 2015 May; 115(10):1351-6. PubMed ID: 25772742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of the side-branch orifice after bifurcation stenting using en-face processing of OCT images: a comparison between Xience V and Resolute Integrity stents.
    Minami Y; Wang Z; Aguirre AD; Lee S; Uemura S; Soeda T; Vergallo R; Raffel OC; Barlis P; Itoh T; Lee H; Fujimoto J; Jang IK
    Coron Artery Dis; 2016 Jan; 27(1):19-28. PubMed ID: 26554662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography.
    Fujino Y; Attizzani GF; Tahara S; Naganuma T; Takagi K; Yabushita H; Wang W; Tanaka K; Matsumoto T; Kawamoto H; Yamada Y; Amano S; Watanabe Y; Warisawa T; Sato T; Mitomo S; Kurita N; Ishiguro H; Hozawa K; Tsukahara T; Motosuke M; Bezerra HG; Nakamura S; Nakamura S
    Int J Cardiol; 2017 Mar; 230():284-292. PubMed ID: 28065691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis.
    Barger AC; Beeuwkes R; Lainey LL; Silverman KJ
    N Engl J Med; 1984 Jan; 310(3):175-7. PubMed ID: 6197652
    [No Abstract]   [Full Text] [Related]  

  • 13. The innateness of coronary artery: Vasa vasorum.
    Han DG
    Med Hypotheses; 2010 Mar; 74(3):443-4. PubMed ID: 19897316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological, Functional, and Biological Vascular Healing Response 6 Months After Drug-Eluting Stent Implantation: A Randomized Comparison of Three Drug-Eluting Stents.
    Nakata T; Fujii K; Fukunaga M; Shibuya M; Kawai K; Kawasaki D; Naito Y; Ohyanagi M; Masuyama T
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):350-7. PubMed ID: 26526816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis.
    Choi BJ; Matsuo Y; Aoki T; Kwon TG; Prasad A; Gulati R; Lennon RJ; Lerman LO; Lerman A
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2473-7. PubMed ID: 25234815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of everolimus-eluting stent incomplete stent apposition: a serial optical coherence tomography analysis.
    Shimamura K; Kubo T; Akasaka T; Kozuma K; Kimura K; Kawamura M; Sumiyoshi T; Ino Y; Yoshiyama M; Sonoda S; Igarashi K; Miyazawa A; Uzui H; Sakanoue Y; Shinke T; Morino Y; Tanabe K; Kadota K; Kimura T
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):23-8. PubMed ID: 25342855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biolimus-a9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography.
    Taglieri N; Ghetti G; Saia F; Moretti C; Gallo P; Dall'Ara G; Palmerini T; Marrozzini C; Rapezzi C; Marzocchi A
    J Invasive Cardiol; 2015 Feb; 27(2):70-7. PubMed ID: 25661757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of drug release kinetics on vascular response to different zotarolimus-eluting stents implanted in patients with long coronary stenoses: the LongOCT study (Optical Coherence Tomography in Long Lesions).
    Guagliumi G; Ikejima H; Sirbu V; Bezerra H; Musumeci G; Lortkipanidze N; Fiocca L; Tahara S; Vassileva A; Matiashvili A; Valsecchi O; Costa M
    JACC Cardiovasc Interv; 2011 Jul; 4(7):778-85. PubMed ID: 21777886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linking drug-eluting stent kinetics and clinical outcomes: insights from optical coherence tomography.
    Brott BC
    JACC Cardiovasc Interv; 2011 Jul; 4(7):786-8. PubMed ID: 21777887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.